Regenerative Medical Technology (RMTG) Price to Sales (2018 - 2026)

Regenerative Medical Technology has reported Price to Sales for 9 years, with the latest figure at 0.17 in Q2 2026.

• On a quarterly basis, Price to Sales fell 66.52% year-over-year to 0.17 in Q2 2026; TTM through Jun 2026 was 0.07, a 29.52% decrease from a year earlier, with the FY2025 full-year figure at 0.13, up 40.65% from the prior year.
• Price to Sales was 0.17 for Q2 2026 at Regenerative Medical Technology, up from 0.15 in the prior quarter.
• The five-year high for Price to Sales was 2.85 in Q1 2022, with the low at 0.15 in Q1 2026.
• Average Price to Sales over 5 years is 0.66, with a median of 0.43 recorded in 2022.
• The sharpest annual moves came in 2022 and 2024: Price to Sales plunged 99.32% in 2022, then jumped 93.22% in 2024.
• Over 5 years, Price to Sales stood at 0.44 in 2022, then slumped by 53.82% to 0.2 in 2023, then rose by 22.67% to 0.25 in 2024, then jumped by 67.85% to 0.42 in 2025, then sank by 59.14% to 0.17 in 2026.
• The last three Price to Sales figures came in at 0.17 (Q2 2026), 0.15 (Q1 2026), and 0.42 (Q4 2025), per Business Quant data.